Sleep Impairment in Ecstasy/Polydrug and Cannabis-Only Users

REFERENCES

• Carhart-Harris RL, Nutt DJ, Munafo M, Wilson SJ. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. [published online ahead of print June 18, 2008]. J Psychopharmacol. 2009;23:249–257. doi:10.1177/0269881108089599.
   Google Scholar
• Baylen CA Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction. 2006;101:933–947.
   PubMed Web of Science ®Google Scholar
• Huxster JK, Pirona A, Morgan MJ. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol. 2006;20:281–290.
   PubMed Web of Science ®Google Scholar
• Montoya AG, Sorrentino R, Lukas SE, Price BH. Long-term neuropsychiatric consequences of “ecstasy” (MDMA): A review. Harvard Rev Psychiatry. 2002;10:212–220.
   PubMed Web of Science ®Google Scholar
• Schierenbeck T, Riemann D, Berger M, Hornyak M. Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana. Sleep Medicine Reviews. 2008;12:381–389.
   PubMed Web of Science ®Google Scholar
• Dughiero G, Schifano F, Forza G. Personality dimensions and psychopathological profile of Ecstasy users. Hum Psychopharmacol. 2001;16:635–639.
   PubMed Web of Science ®Google Scholar
• Soar K, Parrott AC, Fox HC. Persistent neuropsychological problems after 7 years of abstinence from recreational ecstasy (MDMA): A case study. Psycholog Rep. 2004;95:192–196.
   Google Scholar
• Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Human Psychopharmacology Clin Exp. 2006;21:285–298.
   Google Scholar
• Allen R, McCann UD, Ricaurte GA. Persistent Effects of (+)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) on Human Sleep. Sleep. 1993;16:560–564.
   PubMed Web of Science ®Google Scholar
• McCann UD, Ricaurte GA. On the neurotoxicity of MDMA and related amphetamine derivatives. J Clin Psychopharmacol. 1995;15:295–296.
   Web of Science ®Google Scholar
• Insel TR, Battaglia G, Johannessen JN, Marra S. 3,4-Methylenedioxymethamphetamine (“Ecstasy”) selectively destroys brain serotonin terminals in rhesus monkeys. Journal of Pharmacology and Experimental Therapeutics. 1989;249:713–720.
   PubMed Web of Science ®Google Scholar
• Balogh B, Molnar E, Jakus R, Effects of a single dose of 3,4-methylenedioxymethamphetamine on circadian patterns, motor activity and sleep in drug-naive rats and rats previously exposed to MDMA. Psychopharmacology. 2004;173:296–309.
   Google Scholar
• Santucci V, Storme J-J, Soubrié P, Le Fur G. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 14176A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sciences. 1996;58:PL103–PL110.
   PubMed Web of Science ®Google Scholar
• Tassinari CA, Ambrosetto G, Peraita-Adrado MR, Gastaut H. The neuropsychiatric syndrome of Δ-9-tetrahydrocannabinol and cannabis intoxication in naive subjects: A clinical and polygraphic study during wakefulness and sleep. In: Nahas GG, Sutin KM, Harvey D, Agurell S, Pace N. Marihuana and medicine. Totowa, NJ: Humana Press; 1999:649–664.
   Google Scholar
• Nicholson AN, Turner C, Stone BM, Robson PJ. Effect of Δ-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults. J Clin Psychopharmacol. 2004;24:305–313.
   PubMed Web of Science ®Google Scholar
• Budney AJ, Moore BA, Vandrey RG, Hughes JR. The time course and significance of cannabis withdrawal. J Abnorm Psychol. 2003;112:393–402.
   PubMed Web of Science ®Google Scholar
• Arendt M, Rosenberg R, Foldager L, Sher L, Munk-Jorgensen P. Withdrawal symptoms do not predict relapse among subjects treated for cannabis dependence. Am J Addict. 2007;16:461–467.
   PubMed Web of Science ®Google Scholar
• Montgomery C, Fisk JE, Wareing M, Murphy PN. Self reported sleep quality and cognitive performance in ecstasy users. Hum Psychopharmacol. 2007;22:537–548.
   Google Scholar
• Johns M, Hocking B. Daytime sleepiness and sleep habits of Australian workers. Sleep. 1997;20:844–849.
   PubMed Web of Science ®Google Scholar
• Gillberg M, Kecklund G, Akerstedt T. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep. 1994;17:236–241.
   PubMed Web of Science ®Google Scholar
• Smith CS, Reilly C, Midkiff K. Evaluation of three circadian rhythm questionnaires with suggestions for an improved measure of morningness. J Appl Psychol. 1989;74:728–738.
   PubMed Web of Science ®Google Scholar
• Biello SM, Dafters RI. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro. Brain Research. 2001;920:202–209.
   Google Scholar
• Colbron S, Jones M, Biello SM. MDMA alters the response of the circadian clock to a photic and non-photic stimulus. Brain Research. 2002;956:45–52.
   PubMedGoogle Scholar
• Parrott AC, Sisk E, Turner JJD. Psychobiological problems in heavy “ecstasy” (MDMA) polydrug users. Drug Alcohol Depend. 2000;60:105–110.
   PubMed Web of Science ®Google Scholar
• Topp L, Hando J, Dillon P, Roche A, Solowij N. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend. 1999;55:105–115.
   PubMed Web of Science ®Google Scholar
• Cole JC, Sumnall HR. Altered states: the clinical effects of Ecstasy. Pharmacol Ther. 2003;98:35–58.
   PubMed Web of Science ®Google Scholar
• Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA (“ecstasy”) polydrug users. Psychopharmacology. 2002;162:203–214.
   PubMed Web of Science ®Google Scholar
• Morgan MJ. Recreational use of “ecstasy” (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology. 1998;19:252–264.
   PubMed Web of Science ®Google Scholar
• Morgan MJ. Memory deficits associated with recreational use of “ecstasy” (MDMA). Psychopharmacology. 1999;141:30–36.
   PubMed Web of Science ®Google Scholar
• Rodgers J. Cognitive performance amongst recreational users of “ecstasy.” Psychopharmacology. 2000;151:19–24.
   PubMed Web of Science ®Google Scholar
• Horne JA, Ostberg O. Self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97–110.
   PubMedGoogle Scholar